About Shilpa Medicare Ltd 
Shilpa Medicare Ltd
Small Cap
Pharmaceuticals & Biotechnology
Shilpa Medicare Limited, formerly known as Shilpa Antibiotics Private Limited was incorporated as a Private Company on November 20, 1987. The Company changed the status to Public and the name of the Company changed to Shilpa Antibiotics Limited in November, 1993 and later on, was changed to 'Shilpa Medicare Limited' on February 17, 2003. The Company has been promoted by Vishnukant C. Bhutada and his Associates and is engaged in manufacturing of API, Formulation and Development service.
Company Coordinates 
Company Details
#12-6-214/A1, Hyderabad Road Raichur Karnataka : 584135
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Capital Structure 
Present Equity Capital
INR 19.56 Cr
Number of Shares
19.56 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
03-Oct-2025
19.56
19.56
97790908
1
Bonus Issue
13-Apr-2024
9.78
9.78
10989010
1
Qualified Institutional Placement
12-Nov-2021
8.68
8.68
5275000
1
Preferential basis
16-Dec-2017
8.15
8.15
1399994
1
Amalgamation
26-Dec-2016
8.01
8.01
3025000
1
Allotment of Equity To Others
26-Dec-2016
8.01
8.01
3025000
1
Allotment of Equity To Others
06-Nov-2015
7.71
7.71
38550952
1
Stock Split
06-Nov-2015
7.71
7.71
38550952
1
Stock Split
15-May-2014
3.86
7.71
1764705
2
Allotment of Equity Shares To Promoter & Others
15-May-2014
3.86
7.71
1764705
2
Allotment of Equity Shares To Promoter & Others
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
7.9191
Mutual Funds
Held by 9 Schemes (4.26%)
FIIs
Held by 102 FIIs (10.92%)
Promoter with highest holding
Vishnukant Chaturbhuj Bhutada (6.51%)
Highest Public shareholder
Pivotal Enterprises Private Limited (2.25%)
Individual Investors Holdings
23.34%
Management
Designation
Remuneration
Omprakash Inani
Chairman (Non-Executive)
2.5 lacs
Vishnukant Bhutada
Managing Director
3.5 cr
Sharath Reddy Kalakota
Whole-time Director
1.45 cr
Arvind Vasudeva
Independent Director
30.0 lacs
Hetal Gandhi
Independent Director
40.0 lacs
Ritu Tiwary
Company Sec. & Compli. Officer
0
Kamal K Sharma
Independent Director
22.5 lacs
Anita Bandyopadhyay
Independent Director
12.0 lacs
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Income - Product Development
30.27
4.56%
Other Operating Income - Product Development
Other Operating Income - Product Development
Revenue and Profits:
Net Sales:
370 Cr
(Quarterly Results - Sep 2025)
Net Profit:
44 Cr
Pharmaceuticals & Biotechnology
INR 6,490 Cr (Small Cap)
40.00
34
0.15%
0.23
6.73%
2.69






